Literature DB >> 15185498

Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families.

Elizabeth B Haagsma1, Philip N Hawkins, Merrill D Benson, Helen J Lachmann, Alison Bybee, Bouke P Hazenberg.   

Abstract

Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant disorder associated with more than 80 different transthyretin (TTR) mutations. The clinical features of FAP are broad and variable, but knowledge of the pattern and natural history of disease associated with particular mutations nevertheless offers the best guidance for management of individual patients, including the role and timming of treatment by orthotopic liver transplantation. FAP in association with TTR Gly47Glu has been described previously in an Italian kindred, and we report here its phenotype in 7 additional patients from Dutch, British, and American (Finnish) families. Characteristic clinical features included amyloid cardiomyopathy and autonomic failure but, unusually, moderate to severe renal failure was present in more than half of the cases. Only four patients were deemed to be sufficiently fit to undergo orthotopic liver transplantation, and clinical deterioration was generally rapid. These observations support early intervention with orthotopic liver transplantation in patients with FAP associated with TTR Gly47Glu.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185498     DOI: 10.1080/13506120410001682578

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  3 in total

1.  Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

Authors:  Samih H Nasr; Surendra Dasari; Linda Hasadsri; Jason D Theis; Julie A Vrana; Morie A Gertz; Prasuna Muppa; Michael T Zimmermann; Karen L Grogg; Angela Dispenzieri; Sanjeev Sethi; W Edward Highsmith; Giampaolo Merlini; Nelson Leung; Paul J Kurtin
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

2.  Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria.

Authors:  Teodora Chamova; Mariana Gospodinova; Ognian Asenov; Tihomir Todorov; Zornitsa Pavlova; Andrey Kirov; Sylvia Cherninkova; Kristina Kastreva; Ani Taneva; Stanislava Blagoeva; Sashka Zhelyazkova; Plamen Antimov; Kaloian Chobanov; Albena Todorova; Ivailo Tournev
Journal:  Front Neurol       Date:  2022-04-08       Impact factor: 4.003

Review 3.  Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.

Authors:  Yesim Parman; David Adams; Laura Obici; Lucía Galán; Velina Guergueltcheva; Ole B Suhr; Teresa Coelho
Journal:  Curr Opin Neurol       Date:  2016-02       Impact factor: 5.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.